What is the optimal channel density for transmyocardial laser revascularization?
BACKGROUND
Transmyocardial laser revascularization (TMR) has demonstrated reproducible relief of angina in patients with end-stage coronary disease. However, the optimum dose or channel density has not been elucidated.


METHODS
Using a porcine model of chronic myocardial ischemia, 14 animals were treated with CO2 TMR and randomized as follows: group 1 was 1 channel per 2 cm2; group 2 was 1 channel per 1 cm2; and group 3 was 2 channels per 1 cm2. Left ventricular myocardial viability and function were assessed by magnetic resonance imaging (MRI) and echocardiography pretreatment, and repeated 6 weeks later.


RESULTS
The MRI assessment of group 1 (1 channel/2 cm2) and group 2 (1 channel/cm2) demonstrated similar improvement in segmental contractility posttreatment of 12.11% +/- 5.15% and 12.47% +/- 9.51%, respectively. In contrast, group 3 (2 channels/cm2) showed significantly worse segmental contractility posttreatment: -18.52% +/- 7.16% (p = 0.01). Echocardiographic imaging revealed significant improvements in wall thickening in the ischemic zone for group 1 at 0.91 +/- 0.07 cm pretreatment versus 1.30 +/- 0.09 cm posttreatment, (p = 0.01); and for group 2 at 0.93 +/- 0.11 cm versus 1.42 +/- 0.18 cm, (p = 0.01). No significant improvement in wall thickening was seen in group 3 (0.84 +/- 0.06 cm versus 0.88 +/- 0.09 cm, p = n.s.).


CONCLUSIONS
These data corroborate the empiric finding of an effective therapeutic dose range for TMR, 1 channel per 1 to 2 cm2. These results also demonstrate a detrimental effect when channel density is increased above the clinical standard of 1 channel per cm2 to a density of 2 channels per 1 cm2.
Mouli
Samdeep K
SK
Division of Cardiothoracic Surgery, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Fronza
Jeffrey
J
Greene
Rodney
R
Robert
Emmanuel S
ES
Horvath
Keith A
KA
D000818:Animals; D002908:Chronic Disease; D004280:Dobutamine; D004452:Echocardiography; D006339:Heart Rate / Q000187:drug effects; D053685:Laser Therapy / Q000379:methods*; D019028:Magnetic Resonance Imaging, Cine; D009200:Myocardial Contraction; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D011897:Random Allocation; D034421:Sus scrofa; D013908:Thoracotomy; D016277:Ventricular Function, Left
D004280:Dobutamine